 |
9 Diseases |  |
0 Trials |
|
0 Trials |  |
15 News |  |
- ASM-024 / Odan Labs
Enrollment change, Trial termination, Trial primary completion date: Safety, Tolerability and Pharmacokinetics of ASM-024 Administered to Healthy Subjects and Subjects With Moderate Asthma (clinicaltrials.gov) - Feb 9, 2015
P1/2, N=55, Terminated, Sponsor: Asmacure Lt
N=80 --> 55 | Active, not recruiting --> Terminated | Trial primary completion date: Feb 2015 --> Mar 2014; Lack of efficacy
- ASM-024 / Odan Laboratories
Trial completion: Safety, Tolerability, and Clinical Activity of ASM-024 Administered to Patients With GOLD 2 or GOLD 3 Chronic Obstructive Pulmonary Disease (COPD) (clinicaltrials.gov) - Dec 17, 2014
P2, N=14, Completed, Sponsor: Asmacure Ltée
N=80 --> 55 | Active, not recruiting --> Terminated | Trial primary completion date: Feb 2015 --> Mar 2014; Lack of efficacy Active, not recruiting --> Completed
- ASM-024 / Odan Laboratories
Enrollment closed: Safety, Tolerability, and Clinical Activity of ASM-024 Administered to Patients With GOLD 2 or GOLD 3 Chronic Obstructive Pulmonary Disease (COPD) (clinicaltrials.gov) - Aug 8, 2014
P2, N=15, Active, not recruiting, Sponsor: Asmacure Ltée
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- ASM-024 / Odan Laboratories
Trial primary completion date: Safety, Tolerability, and Clinical Activity of ASM-024 Administered to Patients With GOLD 2 or GOLD 3 Chronic Obstructive Pulmonary Disease (COPD) (clinicaltrials.gov) - Jul 23, 2014
P2, N=15, Recruiting, Sponsor: Asmacure Ltée
Recruiting --> Active, not recruiting Trial primary completion date: Jul 2014 --> Oct 2014
- ASM-024 / Odan Labs
Trial primary completion date: Safety, Tolerability and Pharmacokinetics of ASM-024 Administered to Healthy Subjects and Subjects With Moderate Asthma (clinicaltrials.gov) - Jun 1, 2014
P1/2, N=80, Active, not recruiting, Sponsor: Asmacure Lt
Trial primary completion date: Jul 2014 --> Oct 2014 Trial primary completion date: Dec 2013 --> Feb 2015
- ASM-024 / Odan Labs
Enrollment closed: Safety, Tolerability and Pharmacokinetics of ASM-024 Administered to Healthy Subjects and Subjects With Moderate Asthma (clinicaltrials.gov) - Jan 6, 2014
P1/2, N=80, Active, not recruiting, Sponsor: Asmacure Lt
Trial primary completion date: Dec 2013 --> Feb 2015 Recruiting --> Active, not recruiting
- ASM-024 / Odan Laboratories
Enrollment open: Safety, Tolerability, and Clinical Activity of ASM-024 Administered to Patients With GOLD 2 or GOLD 3 Chronic Obstructive Pulmonary Disease (COPD) (clinicaltrials.gov) - Oct 7, 2013
P2, N=15, Recruiting, Sponsor: Asmacure Ltée
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- ASM-024 / Odan Laboratories
New P2 trial: Safety, Tolerability, and Clinical Activity of ASM-024 Administered to Patients With GOLD 2 or GOLD 3 Chronic Obstructive Pulmonary Disease (COPD) (clinicaltrials.gov) - May 14, 2013
P2, N=15, Recruiting, Sponsor: Asmacure Ltée
- | ASM-024 / Odan Labs
New P1/2 trial: Safety, Tolerability and Pharmacokinetics of ASM-024 Administered to Healthy Subjects and Subjects With Moderate Asthma (clinicaltrials.gov) - Feb 13, 2013
P1/2, N=80, Active, not recruiting, Sponsor: Asmacure Lt
- ASM-024 / Odan Laboratories
Trial completion: Safety, Tolerability and Clinical Activity of ASM-024 in Stable Moderate Asthma (clinicaltrials.gov) - Mar 13, 2012
P2, N=20, Completed, Sponsor: Asmacure Ltée
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- ASM-024 / Odan Laboratories
Trial completion: Safety, Tolerability and Clinical Activity of ASM-024 in Subjects With Mild Allergic Asthma (clinicaltrials.gov) - Jan 24, 2012
P2, N=24, Completed, Sponsor: Asmacure Ltée
Active, not recruiting --> Completed Active, not recruiting --> Completed